Manufacturer record
Vision Parental Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Vision Parental Pvt. Ltd were declared Not of Standard Quality between May 2025 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Vision Parental Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Compound Sodium Lactate InjectionI.P. (Ringer Lactate Solution for Injection) (RL 500ml) | CG240705033Mfg 2024-07 · Exp 2027-06 | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab | Oct 2025 |
| Sodium Chloride Injection U.S.P.(3% w/v ) (Hypertonic 3NS 100 ml) | G250146001Mfg 2025-01 · Exp 2027-12 | Particulate MatterParticulate matter | CDL, KolkataCDSCO lab | May 2025 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP | 825D167 | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | May 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.